Cite

HARVARD Citation

    Newhouse, P. et al. (n.d.). Safety and pharmacokinetics of the muscarinic positive allosteric modulator VU319: A phase 1 single dose study. Alzheimer's & dementia. p. n/a. [Online]. 
  
Back to record